Europe dPCR and qPCR Market Forecast to 2030

Europe dPCR and qPCR Market Forecast to 2030

Europe dPCR and qPCR Market Forecast to 2030 – Regional Analysis – By Treatment [Quantitative PCR (qPCR) and Digital PCR (dPCR)], Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), and End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)

Send Enquiry
Item ID: BMIRE00029879 Category: Tag:

$2,840 – $4,440

Description

The Europe dPCR and qPCR market was valued at US$ 2,573.83 million in 2022 and is expected to reach US$ 5,182.96 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Increasing Incidence of Genetic and Infectious Diseases Drive Europe dPCR and qPCR Market

According to the National Organization’s information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, they comprise over 15,500 people diagnosed with genetic disorders. In June 2020, as per Novartis AG (Switzerland) report, ~15,000 individuals have sickle cell disease, and 270 newborns are diagnosed with the condition every year. The COVID-19 outbreak had a significant effect on the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market has a favorable effect on the PCR industry. Nearly all diagnostic tests use RT-PCR to test the people having symptoms of COVID-19 and were urged by healthcare experts to undergo a diagnostic test, while the authorities have not endorsed viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These product include the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium–, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Better testing accessibility will result from this in nations or settings where larger equipment cannot be accommodated due to a lack of resources or space. Thus, increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatments support the growth of the Europe dPCR and qPCR market.

Europe dPCR and qPCR Market Overview

The European dPCR and qPCR market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Government and private funding for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research for novel technology-based applications are likely to be the major factors driving the growth of this market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemption for R&D and new biotech startups are expected to favor the European dPCR and qPCR market growth over the forecast years. However, the effect of Brexit on the European Union may lead to the loss of various alliances, partnerships, ventures, and collaborations, negatively impacting the European dPCR and qPCR market.

Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Europe dPCR and qPCR Market Segmentation

The Europe dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Europe dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Europe dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Europe dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Europe dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Europe dPCR and qPCR market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the Europe dPCR and qPCR market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 9.1% CAGR, the Europe dPCR and qPCR Market is Speculated to be Worth US$ 5,182.96 Million by 2030, Says the Research Team

According to the Research Team’ research, the Europe dPCR and qPCR market was valued at US$ 2,573.83 million in 2022 and is expected to reach US$ 5,182.96 million by 2030, registering a CAGR of 9.1% from 2022 to 2030. Growing adoption of PCR methods in emerging countries and increasing incidence of genetic and infectious diseases are among the critical factors attributed to the Europe dPCR and qPCR market expansion.

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the Europe dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

On the contrary, high costs of PCR systems hampers the growth of Europe dPCR and qPCR market.

Based on treatment, the Europe dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held 73.5% share of the Europe dPCR and qPCR market in 2022, amassing US$ 1,891.85 million. It is projected to garner US$ 3,993.75 million by 2030 to expand at 9.8% CAGR during 2022-2030.

By product, the Europe dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 60.6% share of the Europe dPCR and qPCR market in 2022, amassing US$ 1,559.90 million. It is projected to garner US$ 3,220.88 million by 2030 to expand at 9.5% CAGR during 2022-2030.

By application, the Europe dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held 58.1% share of the Europe dPCR and qPCR market in 2022, amassing US$ 1,495.68 million. It is projected to garner US$ 3,353.06 million by 2030 to expand at 10.6% CAGR during 2022-2030. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Europe dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held 58.1% share of the Europe dPCR and qPCR market in 2022, amassing US$ 1,495.68 million. It is projected to garner US$ 3,353.06 million by 2030 to expand at 10.6% CAGR during 2022-2030.

Based on country, the Europe dPCR and qPCR market is segmented into segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany held 25.3% share of Europe dPCR and qPCR market in 2022, amassing US$ 651.84 million. It is projected to garner US$ 1,406.26 million by 2030 to expand at 10.1% CAGR during 2022-2030.

Key players operating in the Europe dPCR and qPCR market are Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe dPCR and qPCR market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the dPCR and qPCR market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe dPCR and qPCR Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
5. Europe dPCR and qPCR Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Genetic and Infectious Diseases
5.1.2 Rising Investments and Funds for Gene Synthesis
5.1.3 Technological Advancements in PCR Technologies
5.2 Market Restraints
5.2.1 High Costs of PCR Systems
5.2.2 Technical Limitations Associated with qPCR
5.3 Market Opportunities
5.3.1 Growing Adoption of PCR Methods in Emerging Countries
5.4 Future Trends
5.4.1 Development of Droplet Digital PCR
5.5 Impact Analysis:
6. dPCR and qPCR Market – Europe Market Analysis
6.1 Europe dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
7. Europe dPCR and qPCR Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 Europe dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Quantitative PCR
7.3.1 Overview
7.3.2 Quantitative PCR: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Digital PCR
7.4.1 Overview
7.4.2 Digital PCR: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe dPCR and qPCR Market – Revenue and Forecast to 2030 – by Product
8.1 Overview
8.2 Europe dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
8.3 Reagents & Consumables
8.3.1 Overview
8.3.2 Reagents & Consumables: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Software & Services
8.5.1 Overview
8.5.2 Software & Services: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe dPCR and qPCR Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 Europe dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Research Application
9.3.1 Overview
9.3.2 Research Application: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Clinical Application
9.4.1 Overview
9.4.2 Clinical Application: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 Europe dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
9.5 Forensic Application
9.5.1 Overview
9.5.2 Forensic Application: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe dPCR and qPCR Market – Revenue and Forecast to 2030 – by End-User
10.1 Overview
10.2 Europe dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
10.3 Hospitals and Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals and Diagnostic Centers: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biotechnology Companies: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research Laboratories and Academic Institutes
10.5.1 Overview
10.5.2 Research Laboratories and Academic Institutes: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Forensic Laboratories
10.6.1 Overview
10.6.2 Forensic Laboratories: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.7 Clinical Research Organizations
10.7.1 Overview
10.7.2 Clinical Research Organizations: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
11. Europe dPCR and qPCR Market – Country Analysis
11.1.1 Europe dPCR and qPCR Market, by Country
11.1.1.1 UK
11.1.1.1.1 UK: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.1.2 UK: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.1.3 UK: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.1.4 UK: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.1.4.1 UK: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.1.5 UK: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.2 Germany
11.1.1.2.1 Germany: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 Germany: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.2.3 Germany: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.2.4 Germany: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.2.4.1 Germany: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.2.5 Germany: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.3 France
11.1.1.3.1 France: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 France: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.3.3 France: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.3.4 France: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.3.4.1 France: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.3.5 France: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.4 Italy
11.1.1.4.1 Italy: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 Italy: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.4.3 Italy: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.4.4 Italy: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.4.4.1 Italy: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.4.5 Italy: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.5 Spain
11.1.1.5.1 Spain: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.2 Spain: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.5.3 Spain: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.5.4 Spain: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.5.4.1 Spain: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.5.5 Spain: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.6 Rest of Europe
11.1.1.6.1 Rest of Europe: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.6.2 Rest of Europe: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.6.3 Rest of Europe: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.6.4 Rest of Europe: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.6.4.1 Rest of Europe: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.6.5 Rest of Europe: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
12. dPCR and qPCR Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in Europe dPCR and qPCR Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takara Bio Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Qiagen NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Standard BioTools Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Lepu Medical Technology Beijing Co Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 F. Hoffmann-La Roche Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bio-Rad Laboratories Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe dPCR and qPCR Market Segmentation
Table 2. Europe dPCR and qPCR Market, by Clinical Application – Revenue and Forecast to 2030 (US$ Million)
Table 3. UK: Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 4. UK: Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. UK: Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. UK: Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Germany: Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany: Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany: Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 13. France: Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 14. France: Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. France: Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. France: Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Italy: Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy: Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy: Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy: Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 23. Spain: Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain: Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain: Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain: Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain: Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Europe: Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Europe: Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Europe: Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Europe: Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe: Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Organic Growth Strategies in Europe dPCR and qPCR Market
Table 34. Recent Inorganic Growth Strategies in the Europe dPCR and qPCR Market
Table 35. Glossary of Terms, Europe dPCR and qPCR Market

LIST OF FIGURES

Figure 1. Europe dPCR and qPCR Market Segmentation, By Country
Figure 2. Europe – PEST Analysis
Figure 3. Europe dPCR and qPCR Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Europe dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 7. Quantitative PCR: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Digital PCR: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 10. Reagents & Consumables: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Instruments: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Software & Services: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 14. Research Application: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Clinical Application: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Forensic Application: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 18. Hospitals and Diagnostic Centers: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Pharmaceutical and Biotechnology Companies: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories and Academic Institutes: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Forensic Laboratories: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Clinical Research Organizations: Europe dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 24. Europe dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 25. UK: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Germany: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. France: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Italy: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Spain: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Rest of Europe: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Growth Strategies in Europe dPCR and qPCR Market

The List of Companies – Europe dPCR and qPCR Market

1. Abbott Laboratories
2. Agilent Technologies Inc
3. Bio-Rad Laboratories Inc
4. F. Hoffmann-La Roche Ltd
5. Lepu Medical Technology Beijing Co Ltd
6. Qiagen NV
7. Standard BioTools Inc
8. Takara Bio Inc
9. Thermo Fisher Scientific Inc

Reviews

There are no reviews yet.

Be the first to review “Europe dPCR and qPCR Market Forecast to 2030”